RCUS

15.6350.92%
RC

Robert C. Goeltz

Principal Financial Officer & CFO

Mr. Robert C. Goeltz, II, also known as Bob, serves as the Chief Financial Officer and Principal Financial Officer of Arcus Biosciences, Inc. since August 1, 2020 and was its Principal Accounting Officer since August 1, 2020 until March 09, 2023. He had been Chief Financial Officer and Senior Vice President of Unity Biotechnology, Inc. since September 2017 until July 31, 2020. Prior to Unity, Mr. Goeltz served as Chief Financial Officer and Senior Vice President at CytomX Therapeutics, Inc. since May 27, 2015 until May 15, 2017 and its Secretary until May 15, 2017 , in which position he was responsible for investor relations, finance, real estate, insurance, procurement, facilities and information systems. Prior to that, he served as Chief Financial Officer at Onyx Pharmaceuticals, Inc., since joining in October 2013 until May 2015. He spent years at Amgen and held numerous positions in finance. He served as Director of Finance at Tularik. He began his career working in the Assurance practice for Ernst & Young. He began his career as an audit manager for Ernst & Young where he supported a number of initial public offerings. He served as an Executive Director in Amgen’s Corporate Development group, focused on acquisitions and licensing. Previously, Mr. Goeltz held roles of increasing responsibility at Amgen, including in Business Development, Commercial Finance, R&D Finance and Corporate Accounting from 2004 to 2013. He began his career working in the audit practice of Ernst & Young LLP. He is also a Certified Public Accountant (inactive). Mr. Goeltz received his Master of Business Administration degree from UCLA’s Anderson School of Management and his Bachelor of Business Administration degree from Emory University's Goizueta School of Business.

Positions